Michael J Doherty insider trades: Foundation Medicine (FMI) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michael reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 2, 2018 | FMI | ↓ Sell | 2,675 | $136.66 | $366K | Direct | Jul 5, 2018 (3d) |
| Apr 3, 2018 | FMI | ↓ Sell | 2 | $72.40 | $145 | Direct | Apr 5, 2018 (2d) |
| Apr 2, 2018 | FMI | ↓ Sell | 8,190 | $74.87 | $613K | Direct | Apr 3, 2018 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Michael J Doherty's insider trades
Michael J Doherty is Head of Product Development at Foundation Medicine (FMI). Since Apr 2, 2018, Michael has reported no open-market purchases and 3 sales worth $979K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (1 filing), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every FMI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.